THE Therapeutic Goods Administration (TGA) has today announced that the two-dose course of the Russian Federation’s Sputnik V vaccine developed by the Gamaleya Institute will be recognised for the purpose of establishing a traveller’s vaccination status.
The agency said it obtained additional info last week which showed the vaccine “provides protection and potentially reduces the likelihood that an incoming traveller would transmit COVID-19 infection to others while in Australia or become acutely unwell due to COVID-19”.
The supporting information was based on published studies provided by the Russian Government, with the aid of the Australian embassy in Moscow.
The TGA said the recognition of Sputnik would “expand options for the return of international students, travel of workers and travel by business and sportspeople to our country”.
The post TGA ticks Sputnik appeared first on Travel Daily.
Source: traveldaily